Prismasol Injection
Product Images NDC 24571-102

14 FDA label images from Vantive Us Healthcare Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Prismasol (NDC 24571-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vantive Us Healthcare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
An illustrated diagram of an intravenous injection bag labeled PRISMASOL BGK2/3.5 showing its components: a small compartment A with a peel seal, a large compartment B, an injection connector (spike connector), and a Luer connector at the bottom.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
A black and white instructional diagram showing two hands holding the top of an intravenous bag with an arrow pointing downward along the bag, suggesting a step in the preparation or activation process before use.*
FDA Label Image

Figure 3 (Image 03)

Figure 3 (Image 03)
Illustration showing two hands squeezing a flexible medical bag from the sides. The arrows indicate pressing inward toward the center of the bag, which appears to be filled with fluid. The bag has several ports at the top and bottom for intravenous use.*
FDA Label Image

Figure 4a (Image 04)

Figure 4a (Image 04)
Illustration showing a Luer connector on a fluid bag with a close-up of connecting a tube. The steps show pushing and twisting the connector to attach the tubing securely. This diagram instructs on proper connection technique for intravenous administration equipment.*
FDA Label Image

Figure 4b (Image 05)

Figure 4b (Image 05)
This image shows mixing instructions and detailed drug facts for PrismaSol BGK0/2.5 intravenous injection for continuous renal replacement therapy. It includes a barcode with NDC 24571-108-06, concentrations of potassium (0 mEq/L) and calcium (2.5 mEq/L), ingredient amounts before reconstitution, solution pH and osmolality, storage instructions, and manufacturer information (Baxter Healthcare Corporation). The total volume is 5000 mL.*
FDA Label Image

Prismasol Representative Container Label Bgk0/2.5 (Image 06.jpg)

Prismasol Representative Container Label Bgk0/2.5 (Image 06.jpg)
Label for PrismaSol BGK 0/2.5 intravenous injection solution for continuous renal replacement therapy. The 5000 mL bag shows component concentrations before and after reconstitution, including calcium chloride (2.5 mEq/L) and potassium (0 mEq/L). Label includes mixing instructions, bar code, and manufacturer Vantive US Healthcare LLC information.*
FDA Label Image

Prismasol Representative Container Label Bgk4/2.5 (Image 07.jpg)

Prismasol Representative Container Label Bgk4/2.5 (Image 07.jpg)
PrismaSol BGK4/2.5 intravenous injection solution label with active electrolytes potassium (4 mEq/L) and calcium (2.5 mEq/L) highlighted. The 5000 mL replacement solution is produced by Vantive US Healthcare LLC and is used for continuous renal replacement therapy. The label includes instructions, ingredient list, and barcode with NDC 24571-105-06.*
FDA Label Image

Prismasol Representative Container Label Bgk2/3.5 (Image 08.jpg)

Prismasol Representative Container Label Bgk2/3.5 (Image 08.jpg)
Label for PrismaSol BGK2/3.5 Injection, a replacement solution for continuous renal replacement therapy by Vantive US Healthcare LLC. The label provides preparation instructions for mixing two compartments labeled A (250 mL) and B (4750 mL) to total 5000 mL. It lists concentrations of key electrolytes including potassium (2 mEq/L) and calcium (3.5 mEq/L) along with other ingredients. The label also includes barcode, batch, and product number details, plus storage and handling instructions.*
FDA Label Image

Prismasol Representative Container Label Bgk2/0 (Image 09.jpg)

Prismasol Representative Container Label Bgk2/0 (Image 09.jpg)
The image shows mixing instructions for PrismaSol BGK2/0 intravenous injection, a replacement solution for continuous renal replacement therapy by Vantive US Healthcare. It includes steps to squeeze top corners and bag sides to open the seal, a barcode with NDC 24571-102-06, electrolyte concentrations, a detailed table of components before and after reconstitution per 1000 mL, and storage and handling instructions on a 5000 mL bag label.*
FDA Label Image

Prismasol Representative Container Label B22gk4/0 (Image 10.jpg)

Prismasol Representative Container Label B22gk4/0 (Image 10.jpg)
This text panel provides mixing instructions and a medication facts table for PrismaSol B22GK4/0, a replacement solution for continuous renal replacement therapy by Vantive US Healthcare LLC. It includes steps to break and open the seal of the bag, NDC code 24571-111-06, and detailed component concentrations before and after reconstitution. The panel lists ingredients such as magnesium chloride, dextrose anhydrous, sodium chloride, potassium chloride, lactic acid, sodium bicarbonate, and water for injections, with values in mmol/L and mEq/L. Additional information covers storage instructions, usage notes, product volume (5000 mL), batch number, and manufacturing details.*
FDA Label Image

Prismasol Representative Container Label Bk0/0/1.2 (Image 11.jpg)

Prismasol Representative Container Label Bk0/0/1.2 (Image 11.jpg)
PrismaSol BGK0/0/1.2 Replacement Solution for Continuous Renal Replacement Therapy injection, labeled as 5000 mL by Vantive US Healthcare LLC. The label includes mixing steps to break and open the seal, a barcode, and a detailed table listing ingredient weights before reconstitution and electrolyte concentrations after mixing. The product is for prescription use only and manufactured in Italy.*
FDA Label Image

Prismasol Representative Container Label Bgk4/0/1.2 (Image 12.jpg)

Prismasol Representative Container Label Bgk4/0/1.2 (Image 12.jpg)
Drug information panel for PrismaSol BGK4/0/1.2 replacement solution for continuous renal replacement therapy. Includes mixing steps, barcode, electrolyte concentrations, detailed ingredient table before and after reconstitution, and handling/storage instructions. Specifies components like magnesium chloride, dextrose, sodium chloride, potassium chloride, lactic acid, and bicarbonate, with measurements in mEq/L and mmol/L. Shows package volume 5000 mL, labeler Vantive US Healthcare LLC, and product batch and lot numbers.*
FDA Label Image

Phoxillum Representative Container Label Bk4/2.5 (Image 13)

Phoxillum Representative Container Label Bk4/2.5 (Image 13)
Label for PRISMASOL BGK2/3.5 Phoxillum B22K4/0, an injection replacement solution for continuous renal replacement therapy. It provides electrolyte concentrations including 4 mEq/L potassium, 0 mEq/L calcium, 22 mEq/L bicarbonate, and 1 mmol/L phosphate. The label includes mixing instructions, a barcode with NDC# 24571-117-06, a table of contents before and after reconstitution, and states a total volume of 5000 mL. Manufacturer is Baxter Healthcare Corporation, made in Italy.*
FDA Label Image

Phoxillum Representative Container Label B22k4/0 (Image 14)

Phoxillum Representative Container Label B22k4/0 (Image 14)
Label for PRISMASOL BGK4/3.5, a 5000 mL intravenous replacement solution for continuous renal replacement therapy. The label shows detailed composition per 1000 mL before reconstitution, including calcium chloride, magnesium chloride, dextrose anhydrous, sodium chloride, potassium chloride, lactic acid, and sodium bicarbonate. It indicates two compartments: A (250 mL) and B (4750 mL) to be mixed by breaking the red pin. Manufactured by Gambro Renal Products, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.